CareMax Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 1/6

CareMax hat ein Gesamteigenkapital von $20.4M und eine Gesamtverschuldung von $373.1M, was einen Verschuldungsgrad von 1828.7% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $614.2M bzw. $593.8M.

Wichtige Informationen

1,828.7%

Verhältnis von Schulden zu Eigenkapital

US$373.11m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$41.48m
Eigenkapital	US$20.40m
Gesamtverbindlichkeiten	US$593.80m
Gesamtvermögen	US$614.20m

Jüngste Berichte zur Finanzlage

Recent updates

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

Oct 18

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: CMAXDie kurzfristigen Aktiva des Unternehmens ($156.1M) decken seine kurzfristigen Passiva ($507.1M) nicht.

Langfristige Verbindlichkeiten: CMAXDie kurzfristigen Vermögenswerte des Unternehmens ($156.1M) übersteigen seine langfristigen Verbindlichkeiten ($86.7M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: CMAXDie Nettoverschuldung im Verhältnis zum Eigenkapital (1625.4%) wird als hoch angesehen.

Schulden abbauen: CMAXDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 147.2% auf 1828.7% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: CMAX hat auf der Grundlage seines derzeitigen freier Cashflows weniger als ein Jahr Liquiditätsspielraum.

Vorhersage Cash Runway: Unzureichende Daten, um festzustellen, ob CMAX über genügend Cash Runway verfügt, wenn sein freier Cashflow auf der Grundlage historischer Raten weiter wächst oder schrumpft.

CareMax Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

CareMax, Inc. announced delayed annual 10-K filing

CareMax Announces 1-for-30 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

CareMax Receives Non-Compliance Notice From Nasdaq

CareMax, Inc. announced delayed 10-Q filing

Recent updates

High number of new directors

CareMax, Inc. announced delayed annual 10-K filing

Price target decreased by 42% to US$26.00

Price target decreased by 17% to US$37.33

CareMax Announces 1-for-30 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

CareMax Receives Non-Compliance Notice From Nasdaq

New major risk - Share price stability

New minor risk - Market cap size

Consensus EPS estimates fall by 64%

Price target increased by 9.1% to US$6.00

Consensus EPS estimates fall by 105%

New minor risk - Profitability

Caremax, Inc. Reports Unaudited Goodwill Impairment for the Three Months Ended September 30, 2023

CareMax, Inc. to Report Q3, 2023 Results on Nov 09, 2023

CareMax, Inc. Announces Resignation of David J. Shulkin as A Member of the Board of Director

Consensus EPS estimates fall by 18%, revenue upgraded

Price target decreased by 11% to US$6.00

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Revenue Guidance for the Full Year of 2023

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Consensus EPS estimates upgraded to US$0.28 loss, revenue downgraded

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Caremax, Inc. Reaffirms Full Year 2023 Guidance

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates upgraded to US$0.42 loss

Consensus EPS estimates upgraded to US$0.49 loss, revenue downgraded

Consensus revenue estimates fall by 12%

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$8.50

CareMax, Inc. Appoints Ralph De La Torre as Director

Consensus forecasts updated

High number of new and inexperienced directors

CareMax, Inc. (NasdaqGS:CMAX) completed the acquisition of Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC.

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Earnings Guidance for the Full Year 2022

CareMax, Inc. Approves Appointment of Ryan O'quinn as Board of Director

CareMax, Inc. to Report Q3, 2022 Results on Nov 09, 2022

CareMax, Inc., Annual General Meeting, Nov 02, 2022

CareMax: Numbers Are Strong, Compelling Value On Offer

Price target decreased to US$11.10

Consensus estimates of losses per share improve by 14%

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CareMax, Inc. Revises Earnings Guidance for the Full Year 2022

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

CareMax, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Price target decreased to US$11.00

High number of new and inexperienced directors

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

CareMax, Inc. (NasdaqGS:CMAX) entered into an agreement to acquire Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC for approximately $135 million.

Consensus forecasts updated

Price target decreased to US$12.00

Caremax, Inc. Provides Earnings Outlook for the Full Year 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CareMax, Inc. to Report Q1, 2022 Results on May 10, 2022

High number of new and inexperienced directors

Consensus estimates of losses per share improve by 40%

Price target decreased to US$13.25

Consensus forecasts updated

Caremax, Inc. Provides Revenue Guidance for the Full Year 2022

Full year 2021 earnings: EPS misses analyst expectations

CareMax, Inc. to Report Q4, 2021 Results on Mar 08, 2022

CareMax, Inc. Announces Board Changes

Third quarter 2021 earnings released: US$0.035 loss per share (vs US$0.029 loss in 3Q 2020)

High number of new and inexperienced directors

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

CareMax, Inc. announced delayed 10-Q filing

First quarter 2021 earnings released

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital